pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
MWTx-01
Polycythemia Vera
$IRON
Disc Medicine, Inc.
0
catalysts
Preclinical
MX-0612
Obesity
Mesox Ltd
0
catalysts
Preclinical
MX-1604
Liver Cancer
Mesox Ltd
0
catalysts
Preclinical
MYCO-004
Smoking Cessation
Noveris Health Sciences Inc
← prev
page 110 of 231
next →
131
Pain
89
Neurology
1
0
catalysts
MYDAYIS
MYDAYIS (DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE)
TAKEDA PHARMS USA
0
catalysts
MYOVIEW
MYOVIEW (TETROFOSMIN)
MEDI-PHYSICS
0
catalysts
Phase 2
MZ-1866
Unspecified Genetic Disorders
Mahzi Therapeutics Inc
0
catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0
catalysts
Phase 3
Maci
Articular Cartilage Defect
$VCEL
Vericel Corp
0
catalysts
Preclinical
Marburg vaccine
Marburgvirus Infections (Marburg Hemorrhagic Fever)
$SNGX
SOLIGENIX, INC.
0
catalysts
Marketed
Maxitrol
Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate Sandoz ((dexamethasone + neomycin sulfate + polymyxin B [INN]))
Anterior Segment Inflammation
Sandoz Inc
0
catalysts
Phase 3
Melpida
Paraplegia
Elpida Therapeutics
0
catalysts
Marketed
Menopur
Menopur (menotropins)
Anovulation
Ferring Pharmaceuticals Inc
0
catalysts
Phase 2
MesenCure
Acute Respiratory Distress Syndrome
Bonus BioGroup Ltd
0
catalysts
Phase 2
MesoCancerVac
MesoPher
Malignant Mesothelioma
Amphera BV
0
catalysts
Marketed
Mestinon
Mestinon (pyridostigmine bromide)
Myasthenia Gravis
Bausch Health US LLC
0
catalysts
Marketed
Metastron
Metastron (strontium chloride sr 89)
Bone Metastasis
Q BioMed Inc
0
catalysts
Marketed
Methylin
Methylin (methylphenidate hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
SpecGx LLC
0
catalysts
Preclinical
MiNK-215
Melanoma
$INKT
MiNK Therapeutics, Inc.
0
catalysts
Marketed
Micardis HCT
Micardis HCT ((hydrochlorothiazide [INN] + telmisartan))
Hypertension
Boehringer Ingelheim Corp
0
catalysts
Marketed
Migranal
Migranal (dihydroergotamine mesylate)
Migraine
Bausch Health US LLC
0
catalysts
Marketed
Miostat
Miostat (carbachol [INN])
Miosis
$NVS
NOVARTIS AG
0
catalysts
Phase 2
Motrem
Septic Shock
Triggering receptor expressed on myeloid cells 1
Inotrem SA
0
catalysts
Phase 1
MuSK-CAART
Myasthenia Gravis
$CABA
Cabaletta Bio, Inc.
0
catalysts
Phase 3
Multikine
Head And Neck Squamous Cell Carcinoma (HNSC)
CEL-SCI Corp
0
catalysts
Phase 2
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0
catalysts
Preclinical
MyoDys45-55
Duchenne Muscular Dystrophy
MyoGene Bio LLC
0
catalysts
Phase 1
MyoPAXon
Duchenne Muscular Dystrophy
Myogenica Inc
0
catalysts
Preclinical
N-0651
Age Related Macular Degeneration
Naegis Pharmaceuticals Inc
0
catalysts
pre_registration
N-115
Chronic Obstructive Pulmonary Disease (COPD)
EmphyCorp Inc
0
catalysts
